Table 1 Patients' characteristics
Total number of patients | 631 |
|---|---|
Patients from centre #1 | 352 |
Patients from centre #2 | 53 |
Patients from centre #3 | 226 |
Male/female | 385/246 |
Median age (range) | 61.2 years (28.9–84.9) |
Colon/rectum | 464/167 |
PS 0/1/2/unknown | 337/156/30/108 |
Stage at diagnosis | |
A | 2 |
B | 72 |
C | 169 |
D | 385 |
Unknown | 3 |
Previous adjuvant therapy | |
Yes/no | 172/459 |
Metastatic site at study entry | |
1 mts site | 450 (71.3%) |
>1 mts site | 181 (28.7%) |
Liver | 457/631 (72.4%) |
Lung | 165/631 (26.1%) |
Abdomen | 217/631 (34.4%) |
Bone | 7/631 (1.1%) |
Mean Hb level (±s.e.m.) | 12.5 (±0.07) g dl−1 |
Male | 12.8 (±1.8) |
Female | 12.0 (±1.5) (P<0.0001) |
Colon | 12.5 (±0.08) |
Rectum | 12.6 (±0.14) (P=NS) |
PS 0 | 12.8 (±0.09) |
PS 1 | 12.2 (±0.14) |
PS 2 | 11.3 (±0.33) (P<0.0001) |
1 mts site | 12.5 (±0.08) |
>1 mts site | 12.4 (±0.14) (P=NS) |
Liver mts | 12.4 (±0.08) |
No liver mts | 12.7 (±0.13) (P=0.03) |
Lung mts | 12.4 (±0.08) |
No lung mts | 12.9 (±0.13) (P<0.01) |
